Meningococcal disease.
Rosenstein
N E
NE
Meningitis and Special Pathogens Branch, Division of Bacterial and Myocotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. nar5@cdc.gov
Perkins
B A
BA
Stephens
D S
DS
Popovic
T
T
Hughes
J M
JM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D002462:Cell Membrane; D004196:Disease Outbreaks; D014943:Global Health; D006801:Humans; D008589:Meningococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D022401:Meningococcal Vaccines; D009345:Neisseria meningitidis / Q000145:classification / Q000648:ultrastructure; D012307:Risk Factors; D012703:Serotyping; D014481:United States / Q000453:epidemiology; D018074:Vaccines, Conjugate
D000900:Anti-Bacterial Agents; D022401:Meningococcal Vaccines; D018074:Vaccines, Conjugate